CASP3 and cancer: As a result, reducing caspase activity is a common pathway by which cancers avoid apoptosis, with reduced expression or mutations reported for both initiator (caspase 2, 8, and 10) and executioner caspases (caspase 3, 6, and 7) in a range of cancers (191).